SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 16th, 2024 • Vaxart, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledJanuary 16th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 16, 2024, between Vaxart, Inc., a Delaware corporation (the “Company”), and RA Capital Healthcare Fund, L.P. (the “Purchaser”).